Today in Brussels, the European Cancer Patient Coalition called for more concrete actions to increase access and awareness of cancer genetic testing and other types of biomarkers at the event held in the European Parliament. Genetic testing and other types of biomarker testing help to identify the “Achilles' heel” of different types of cancer, ensuring that the right person receives the right treatment at the right time. Hosted by MEP Marlene Mizzi (S&D, Malta), the event was focused on Cancer Biomarkers in the Era of Personalised Medicines.